Home
Coronavirus
Manivasc
About Us
History
Ethic and Integrity
Mission and Values
Industrial Operations
Annual Report
We are B Corp
Company Information - Brazil and Globally
Therapeutic Areas
Respiratória
Neonatologia
Cardiovascular
Doenças Raras
MIP
Produtos
Contacts
Health professionals
Your Health
Apnea of Prematurity
Asthma
COPD
Cystic Fibrosis
Hypertension
Rhinitis
Respiratory Distress Syndrome (RDS)
Thalassemia
Acessar Program
Popular Pharmacy Program
Videos
Pharmacovigilance
Pipeline and New Business
Pipeline
New business
Clinical Research
Corporate Responsibility
Chiesi foundation
HSE
Programs
Sustainability
Sustainability at Chiesi
We ACT – Sustainability Manifesto
Ethics
Transparency
People at the Center
Environment
Supply Chain Sustainability
Community
Chiesi Foundation
Human Resources
Start your career at Chiesi
Available Vacancies
Press
News
Press Releases
Acknowledgments
Press Contact
Home
|
Contacts
|
Health professionals
|
Pharmacovigilance
|
Chiesi Group
BR
EN
Welcome to Chiesi
Brazil
Digite ao menos 3 caracteres
About Us
History
Ethic and Integrity
Mission and Values
Industrial Operations
Annual Report
We are B Corp
Company Information - Brazil and Globally
Therapeutic Areas
Respiratory
Neonatology
Cardiovascular
Rare diseases
OTC
Products
Your Health
Apnea of Prematurity
Asthma
COPD
Cystic Fibrosis
Hypertension
Rhinitis
Respiratory Distress Syndrome (RDS)
Thalassemia
Acessar Program
Popular Pharmacy Program
Videos
Pipeline and New Business
Pipeline
New business
Clinical Research
Corporate Responsibility
Chiesi foundation
HSE
Programs
Sustainability
Sustainability at Chiesi
We ACT – Sustainability Manifesto
Ethics
Transparency
People at the Center
Environment
Supply Chain Sustainability
Community
Chiesi Foundation
Human Resources
Start your career at Chiesi
Available Vacancies
Press
News
Press Releases
Acknowledgments
Press Contact
This site uses cookies. Continuing to navigate is considered accepted usage.
More info
CLOSE
Home page
>
Therapeutic areas
Edit email address
Invalid email
Email Sent
Respiratory
Chiesi Farmaceutici is fully committed to the care and improvement of the quality of life of people suffering from respiratory diseases including...
Neonatology
Normally, delivery takes place between the 37th and the 42nd week of gestation. By that time, the foetus is fully formed and developed enough to be...
Cardiovascular
Cardiovascular diseases (CVD) are the number one cause of death globally: more people die annually from CVDs than from any other cause.
Rare diseases
The term rare applies to those diseases affecting a limited number of people with a prevalence below a given cut-off point, which is codified by the...
OTC
Exempt Prescription drugs (MIP) are those that do not require a prescription for purchase.
Products
Chiesi Pharmaceuticals has dedicated over 80 years to the research and development of drugs and technologies in the pharmaceutical field,...
CHIESI ON THE WEB
Áustria
Chiesi Pharmaceuticals GmbH
Bélgica
Chiesi sa
Brasil
Chiesi Farmacêutica Ltda
Bulgária
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
República Tcheca
Chiesi CZ s.r.o.
França
Chiesi S.A.
Alemanha
Chiesi GmbH
Grécia
Chiesi Hellas Pharmaceuticals S.A.
Hungria
Chiesi Hungary Kft.
Itália
-
México
Chiesi Mexico S.A. de C.V.
Paquistão
Chiesi Pharmaceuticals (Pvt) Limited
Polônia
Chiesi Polonia
Romênia
Chiesi România S.r.l.
Rússia
Chiesi Pharmaceuticals LLC
República Eslovaca
Chiesi Slovakia s.r.o
Eslovênia
Chiesi Slovenija, d.o.o
Espanha
Chiesi España S.A.
Suécia
Chiesi Pharma AB
Holanda
Chiesi Pharmaceuticals B.V.
Turquia
Chiesi İlaçTicaret Limited Sirketi A.Ş.
Reino Unido
Chiesi Ltd
Estados Unidos
Chiesi Usa Inc.
